NCT06915389View on ClinicalTrials.gov

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 22, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Gastric CancerImmunotherapyAdverse EventMetabonomicsLipidomics
Trial Locations (1)

810000

RECRUITING

Qinghai Red Cross Hospital, Xining

All Listed Sponsors
lead

Qinghai Red Cross Hospital

OTHER